Browsing by Author Nadal, Ernest
Showing results 21 to 40 of 43
< previous
next >
| Issue Date | Title | Author(s) |
|---|---|---|
| 1-Dec-2019 | Impact of baseline steroids on efficacy of programmed cell death-1 (PD-1) and programmed death-ligand 1 (PD-L1) blockade in patients with advanced non-small cell lung cancer | Jove, Maria; Vilariño, Noelia; Nadal, Ernest |
| 1-Jan-2021 | Induction treatment in patients with stage III non-small cell lung cancer | Palmero, Ramón; Vilariño, Noelia; Navarro Martin, Arturo; Nadal, Ernest |
| 6-Aug-2020 | Inhibition of DDR1 enhances in vivo chemosensitivity in KRAS-mutant lung adenocarcinoma | Nokin, Marie-Julie; Darbo, Elodie; Travert, Camille; Drogat, Benjamin; Lacouture, Aurélie; San José, Sonia; Cabrera, Nuria; Turcq, Béatrice; Prouzet-Mauleon, Valérie; Falcone, Mattia; Villanueva Garatachea, Alberto; Wang, Haiyun; Herfs, Michael; Mosteiro, Miguel; Jänne, Pasi A.; Pujol, Jean-Louis; Maraver, Antonio; Barbacid, Mariano; Nadal, Ernest; Santamaria, David; Ambrogio, Chiara |
| 2-Feb-2022 | Insights into cisplatin-induced neurotoxicity and mitochondrial dysfunction in Caenorhabditis elegans | Martínez Fernández, Carmen; Bergamino, Milana; Schiavi, Alfonso; Brena, David; Ventura, Natascia; Honnen, Sebastian; Villanueva, Alberto; Nadal, Ernest; Cerón, Julián |
| 1-Feb-2021 | Integrative transcriptome analysis of malignant pleural mesothelioma reveals a clinically relevant immune-based classification | Alay, Ania; Cordero Romera, David; Hijazo Pechero, Sara; Aliagas Marín, Elisabeth; López Dóriga Guerra, Adriana; Marín, Raúl; Palmero, Ramón; Llatjós, Roger; Escobar Campuzano, Ignacio; Ramos Izquierdo, Ricard; Padrones, Susana; Moreno Aguado, Víctor; Nadal, Ernest; Solé Acha, Xavier |
| 24-Apr-2014 | Linkage of DNA methylation quantitative trait loci to human cancer risk | Heyn, Holger; Sayols, Sergi; Moutinho, Cátia; Vidal, Enrique; Sanchez-Mut, Jose Vicente; Stefansson, Olafur A.; Nadal, Ernest; Moran, Sebastian; Eyfjord, Jorunn E.; González Suárez, Eva; Pujana Genestar, M. Ángel; Esteller, Manel |
| 1-Dec-2023 | Molecular profiling and feasibility using a comprehensive hybrid capture panel on a consecutive series of non-small-cell lung cancer patients from a single centre | Mosteiro, Miguel; Azuara García, Daniel; Alay, Ania; Gausachs Romero, Mireia; Varela, M.; Baixeras, N.; Pijuan, Lara; Ajenjo-Bauza, M.; López Dóriga Guerra, Adriana; Teulé-Vega, Àlex; Solanes, Aleix; Palmero, Ramón; Brenes, Jesús; Jové, M.; Padrones, Susana; Moreno Aguado, Víctor; Cordero, D.; Matias-Guiu, Xavier; Lázaro, Conxi; Nadal, Ernest |
| 1-Nov-2019 | Multicenter Evaluation of the Fully Automated PCR-Based Idylla EGFR Mutation Assay on Forman-Fixed, Paraffin-Embedded Tissue of Human Lung Cancer | Evrard, Solène M.; Taranchon Clermont, Estelle; Rouquette, Isabelle; Murray, Samuel; Dintner, Sebastian; Nam Apostolopoulos, Yun Chung; Bellosillo, Beatriz; Varela Rodríguez, Mar; Nadal, Ernest; Wiedorn, Klaus H.; Melchior, Linea; Andrew, Emma; Jones, Mary; Ridgway, Jennifer; Frykman, Christina; Lind, Linda; Rot, Mitja; Kern, Izidor; Speel, Ernst J. M.; Roemen, Guido M. J. M.; Trincheri, Nicol; Freiberger, Sandra N.; Rechsteiner, Markus |
| 22-Jun-2020 | Multiple low dose therapy as an effective strategy to treat EGFR inhibitor-resistant NSCLC tumours | Fernandes Neto, João M.; Nadal, Ernest; Bosdriesz, Evert; Ooft, Salo N.; Farré, Lourdes; McLean, Chelsea; Klarenbeek, Sjoerd; Jurgens, Anouk; Hagen, Hannes; Wang, Liqin; Felip, Enriqueta; Martínez Martí, Alex; Vidal-Bel, August; Voest, Emile; Wessels, Lodewyk F. A.; van Tellingen, Olaf; Villanueva Garatachea, Alberto; Bernards, René |
| 1-Jul-2021 | On target: Rational approaches to KRAS inhibition for treatment of non-small cell lung carcinoma | Lindsay, Colin R.; Garassino, Marina C.; Nadal, Ernest; Öhrling, Katarina; Scheffler, Matthias; Mazières, Julien |
| 1-Oct-2021 | Overall treatment strategy for patients with metastatic NSCLC with activating EGFR mutations | Hayashi, Hidetoshi; Nadal, Ernest; Gray, Jhanelle E.; Ardizzoni, Andrea; Caria, Nicola; Puri, Tarun; Grohe, Christian |
| 1-Aug-2023 | Pembrolizumab as first-line treatment for advanced NSCLC in older adults: A phase II clinical trial evaluating geriatric and quality-of-life outcomes | Blanco, Remei; Dómine, Manuel; González, José Luis; Loutfi, Sami; Alfaro, Jordi; Saldaña, Juana; Rubio, Jaime; Campos Bonilla, Begoña; Hidalgo, Julia; Barba, Andrés; Márquez, Diego; Martin, Maria; Olaverri, Amaya; Nadal, Ernest |
| 1-Apr-2021 | Perilesional edema in brain metastases as predictive factor of response to systemic therapy in non-small cell lung cancer patients: a preliminary study | Alemany, Montse; Domènech, Marta; Argyriou, Andreas A.; Vilariño, Noelia; Majós Torró, Carlos; Naval Baudin, Pablo; Lucas, Anna; Palmero, Ramón; Simó, Marta; Nadal, Ernest; Bruna, Jordi |
| 1-Oct-2023 | Phase II Trial of Atezolizumab Combined With Carboplatin and Pemetrexed for Patients With Advanced Nonsquamous Non–Small-Cell Lung Cancer With Untreated Brain Metastases (Atezo-Brain, GECP17/05) | Nadal, Ernest; Rodríguez-abreu, Delvys; Simó, Marta; Massutí, Bartomeu; Juan, Oscar; Huidobro, Gerardo; López, Rafael; De Castro, Javier; Estival, Anna; Mosquera, Joaquín; Sullivan, Ivana; Felip, Enriqueta; Blasco, Ana; Guirado, Maria; Pereira, Eva; Vilariño, Noelia; Navarro, Valentín; Bruna, Jordi |
| 2-Mar-2021 | Prognostic value of the preoperative lymphocyte-to-monocyte ratio for survival after lung cancer surgery | Ramos Izquierdo, Ricard; Macía, Ivan; Navarro Martin, Arturo; Déniz, Carlos; Rivas, Francisco; Ureña Lluveras, Anna; Masuet Aumatell, Cristina; Moreno, Camilo; Nadal, Ernest; Escobar Campuzano, Ignacio |
| 22-Jul-2021 | RELAY Subgroup Analyses by EGFR Ex19del and Ex21L858R Mutations for Ramucirumab Plus Erlotinib in Metastatic Non–Small Cell Lung Cancer | Nakagawa, Kazuhiko; Nadal, Ernest; Garon, Edward B.; Nishio, Makoto; Seto, Takashi; Yamamoto, Nobuyuki; Park, Keunchil; Shih, Jin-yuan; Paz Ares, Luis; Frimodt Moller, Bente; Zimmermann, Annamaria H.; Wijayawardana, Sameera; Visseren Grul, Carla; Reck, Martin; RELAY study investigators |
| 4-Feb-2021 | SEOM clinical guidelines for the treatment of malignant pleural mesothelioma (2020) | Nadal, Ernest; Bosch Barrera, Joaquim; Cedrés, S.; Coves, J.; García Campelo, R.; Guirado, M.; López Castro, R.; Ortega, A. L.; Vicente, D.; Castro Carpeño, Javier de |
| 19-Aug-2021 | Silibinin Suppresses Tumor Cell-Intrinsic Resistance to Nintedanib and Enhances Its Clinical Activity in Lung Cancer | Bosch Barrera, Joaquim; Verdura, Sara; Ruffinelli, José Carlos; Carcereny, Enric; Sais, Elia; Cuyàs, Elisabet; Palmero, Ramón; Lopez Bonet, Eugeni; Hernández Martínez, Alejandro; Oliveras Serrat, Glòria; Buxó, Maria; Izquierdo, Angel; Morán, Teresa; Nadal, Ernest; Menendez, Javier A. |
| 20-Apr-2020 | Starvation and antimetabolic therapy promote cytokine release and recruitment of immune cells | Püschel, Franziska; Favaro, Francesca; Redondo Pedraza, Jaime; Lucendo, Estefanía; Iurlaro, Raffaella; Marchetti, Sandrine; Majem, Blanca; Eldering, Eric; Nadal, Ernest; Ricci, Jean-Ehrland; Chevet, Eric; Muñoz Pinedo, Cristina |
| 1-Jan-2021 | Systematic review of stereotactic body radiotherapy in stage III non-small cell lung cancer | Alcibar, Olwen Leaman; Nadal, Ernest; Romero Palomar, Inmaculada; Navarro Martin, Arturo |